课题基金 / 基金详情

Molecular Targeting Of Innate Immune Signalling Pathways In Cancer And Auto-Inflammatory Diseases

Molecular Targeting Of Innate Immune Signalling Pathways In Cancer And Auto-Inflammatory Diseases
癌症和自身炎症性疾病中先天免疫信号通路的分子靶向
批准号:
nhmrc : GNT1107149
负责人:
Prof John Silke
金额:
$75.33万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Research Fellowships
财政年份:
2016
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2016-01-01 至 --

项目摘要

项目成果

Prof John Silke的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To achieve an accurate molecular understanding of innate immune system receptor signalling, both intracellularly and in whole organisms, in health and disease. This knowledge will then be used to generate better treatments for the extensive range of human diseases that are caused or exacerbated by dysfunctional innate immune signalling, including Crohn's disease, psoriasis and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Targeting Of Innate Immune Signalling Pathways In Cancer And Auto-Inflammatory Diseases
Research Fellowship
The Role of Necroptosis in Inflammatory Skin Diseases
Role of transformation and IAPs in sensitivity of cells to TNFalpha
国内基金
海外基金
Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
  • 批准号:
    81873493
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    沈德良
  • 依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2011
  • 负责人:
    陈雪芹
  • 依托单位: